Heart rate variability predicts outcome in children with pulmonary arterial hypertension

International Journal of Cardiology

Volumn 142, Issue 2, 2010, Pages 159-165

  Lammers, Astrid E ^a   Munnery, Elizabeth ^a   Hislop, Alison A ^b   Haworth, Sheila G ^a,b  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Autonomic dysfunction; Heart rate variability; Paediatric; Pulmonary arterial hypertension

Indexed keywords

ARTICLE; BIVARIATE ANALYSIS; CHILD; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; CLINICAL ARTICLE; DISEASE CLASSIFICATION; DISEASE SEVERITY; EXERCISE TEST; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART HEMODYNAMICS; HEART RATE VARIABILITY; HEART RIGHT VENTRICLE FUNCTION; HOLTER MONITORING; HUMAN; LUNG TRANSPLANTATION; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PULMONARY HYPERTENSION; RISK ASSESSMENT; SCHOOL CHILD; SYNCOPE; UNIVARIATE ANALYSIS; WORLD HEALTH ORGANIZATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HEART TRANSPLANTATION; HUMANS; HYPERTENSION, PULMONARY; MALE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77953479247     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.12.087     Document Type: Article

References (29)

1. Folino A.F., Bobbo F., Schiraldi C., et al. Ventricular arrhythmias and autonomic profile in patients with primary pulmonary hypertension. Lung 181 (2003) 321-328
2. Rosas-Peralta M., Sandoval-Zarate J., Attie F., et al. Clinical implications and prognostic significance of the study on the circadian variation of heart rate variability in patients with severe pulmonary hypertension. Gac Med Mex 142 (2006) 19-28
3. Davos C.H., Davlouros P.A., Wensel R., et al. Global impairment of cardiac autonomic nervous activity late after repair of tetralogy of Fallot. Circulation 106 (2002) I69-75
4. Davos C.H., Francis D.P., Leenarts M.F., et al. Global impairment of cardiac autonomic nervous activity late after the Fontan operation. Circulation 108 Suppl 1 (2003) II180-II185
5. Lammers A., Kaemmerer H., Hollweck R., et al. Impaired cardiac autonomic nervous activity predicts sudden cardiac death in patients with operated and unoperated congenital cardiac disease. J Thorac Cardiovasc Surg 132 (2006) 647-655
6. La Rovere M.T., Bigger Jr. J.T., Marcus F.I., et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 351 (1998) 478-484
7. Lombardi F., Sandrone G., Pernpruner S., et al. Heart rate variability as an index of sympathovagal interaction after acute myocardial infarction. Am J Cardiol 60 (1987) 1239-1245
8. Ghuran A., Reid F., La Rovere M.T., et al. Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (The Autonomic Tone and Reflexes After Myocardial Infarction substudy). Am J Cardiol 89 (2002) 184-190
9. La Rovere M.T., Pinna G.D., Hohnloser S.H., et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation 103 (2001) 2072-2077
10. Kleiger R.E., Miller J.P., Bigger J.T., et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 59 (1987) 256-262
11. Routledge H.C., Chowdhary S., and Townend J.N. Heart rate variability-a therapeutic target. J Clin Pharm Ther 27 (2002) 85-92
12. Bolger A.P., Sharma R., Li W., et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 106 (2002) 92-99
13. Diller G.P., Dimopoulos K., Okonko D., et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation 112 (2005) 828-835
14. Chin K.M., Kim N.H., and Rubin L.J. The right ventricle in pulmonary hypertension. Coron Artery Dis 16 (2005) 13-18
15. van Wolferen S.A., Marcus J.T., Boonstra A., et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 28 (2007) 1250-1257
16. Opie L.H. Cellular basis for therapeutic choices in heart failure. Circulation 110 (2004) 2559-2561
17. Ishikawa S., Honda M., Yamada S., et al. Biventricular down-regulation of beta-adrenergic receptors in right ventricular hypertrophy induced by monocrotaline. Jpn Circ J 55 (1991) 1077-1085
18. Sakamaki F., Satoh T., Nagaya N., et al. Correlation between severity of pulmonary arterial hypertension and 123I-metaiodobenzylguanidine left ventricular imaging. J Nucl Med 41 (2000) 1127-1133
19. Fauchier L., Melin A., Eder V., et al. Heart rate variability in rats with chronic hypoxic pulmonary hypertension. Ann Cardiol Angeiol (Paris) 55 (2006) 249-254
20. Hoeper M.M., Oudiz R.J., Peacock A., Tapson V.F., et al. End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives. J Am Coll Cardiol 43 (2004) 48S-55S
21. Miyamoto S., Nagaya N., Satoh T., et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 161 (2000) 487-492
22. Hoeper M.M., Pletz M.W., Golpon H., et al. Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension. Eur Respir J 29 (2007) 944-950
23. Olschewski H., Simonneau G., Galie N., et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 347 (2002) 322-329
24. D'Alonzo G.E., Barst R.J., Ayres S.M., et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115 (1991) 343-349
25. Sandoval J., Bauerle O., Palomar A., Gomez A., et al. Survival in primary pulmonary hypertension. Validation of a prognostic equation. Circulation 89 (1994) 1733-1744
26. Sitbon O., Humbert M., Nunes H., Parent F., et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 40 (2002) 780-788
27. McLaughlin V.V., Shillington A., and Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation 106 (2002) 1477-1482
28. Galie N., Hinderliter A.L., Torbicki A., et al. Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension. J Am Coll Cardiol 41 (2003) 1380-1386
29. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150